Zymeworks Announces Participation in Upcoming Investor Conferences

Rhea-AI Summary

Zymeworks (Nasdaq: ZYME) announced management will participate in two investor conferences in April 2026: Needham 25th Annual Virtual Healthcare Conference and Bloom Burton & Co. Healthcare Investor Conference.

Presentations: April 15, 2026 at 10:15 AM ET (virtual) and April 21, 2026 in Toronto, ON. According to the company, management will hold one-on-one meetings and investor presentations at both events.

VANCOUVER, British Columbia, March 24, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced that management will participate in the following upcoming investor conferences:

• Needham 25^th Annual Virtual Healthcare Conference: Zymeworks’ management will participate in virtual one-on-one meetings and present on April 15 at 10:15 am Eastern Time (ET).
• 2026 Bloom Burton & Co. Healthcare Investor Conference: Zymework’s management will participate in one-on-one meetings and present on April 21 in Toronto, ON.

About Zymeworks Inc.

Zymeworks is a global biotechnology company managing a portfolio of licensed healthcare assets and developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease. Zymeworks’ asset and royalty aggregation strategy focuses on optimizing positive future cash flows from an emerging portfolio of licensed products such as Ziihera® (zanidatamab-hrii) and other licensed products and product candidates, such as pasritamig. In addition, Zymeworks is also building a portfolio of healthcare assets that can generate strong cash flows, while supporting the development of innovative medicines. Zymeworks engineered and developed Ziihera, a HER2-targeted bispecific antibody using the Zymeworks’ proprietary Azymetric™ technology and has entered into separate agreements with BeOne Medicines Ltd. (formerly BeiGene, Ltd.) and Jazz Pharmaceuticals Ireland Limited granting each exclusive rights to develop and commercialize zanidatamab in different territories. Zymeworks is rapidly advancing a robust pipeline of product candidates, leveraging its expertise in both antibody drug conjugates and multispecific antibody therapeutics targeting novel pathways in areas of significant unmet medical need. Zymeworks’ complementary therapeutic platforms and fully integrated drug development engine provide the flexibility and compatibility to precisely engineer and develop highly differentiated antibody-based therapeutics. These capabilities have been further leveraged through strategic partnerships with global biopharmaceutical companies. For information about Zymeworks, visit www.zymeworks.com and follow @ZymeworksInc on X.

Contacts:

Investor Inquiries:
Shrinal Inamdar
Vice President, Investor Relations
(604) 678-1388
ir@zymeworks.com   

Media Inquiries:
Diana Papove
Vice President, Corporate Communications
(604) 678-1388
media@zymeworks.com

FAQ

When will Zymeworks (ZYME) present at the Needham 25th Annual Virtual Healthcare Conference in 2026?

Zymeworks will present on April 15, 2026 at 10:15 AM Eastern Time. According to the company, management will participate in virtual one-on-one meetings and deliver a presentation during the Needham virtual conference that day.

What is Zymeworks' (ZYME) schedule for the Bloom Burton & Co. Healthcare Investor Conference in April 2026?

Zymeworks will participate and present on April 21, 2026 in Toronto, Ontario. According to the company, management plans one-on-one investor meetings and an in-person presentation at the Bloom Burton conference.

How can investors attend Zymeworks' (ZYME) Needham virtual presentation on April 15, 2026?

Investors can access the Needham presentation virtually on April 15 at 10:15 AM ET. According to the company, management will join virtual one-on-one meetings and present via the conference's virtual platform.

Will Zymeworks (ZYME) hold one-on-one investor meetings at both April 2026 conferences?

Yes. Zymeworks management will hold one-on-one meetings at both the Needham virtual event and the Bloom Burton in-person conference. According to the company, these meetings accompany scheduled presentations on April 15 and April 21, 2026.

What topics will Zymeworks (ZYME) cover in its April 2026 investor presentations?

The company will discuss corporate updates, licensed assets and pipeline progress during the April presentations. According to the company, management presentations and one-on-one meetings will cover recent corporate developments and the biotherapeutics pipeline.